




Nanjing Xinbell Pharmaceutical Technology Co., Ltd. was established in October 2014. It is located in Nanjing, Jiangsu Province, in the Yangtze River Delta Region. Xinbell is a professional company specializing in developing, producing and marketing of pharmaceutical intermediates.
The company’s products are mainly involved in the field of anti-tumor, epilepsy, rheumatism, cardiovascular and cerebrovascular and have been sold to more than ten countries, such as Europe, India, Japan, South Korea and Southeast Asia. At the present, the company cooperates with three GMP complied factories and two domestic university and R & D center.
October 14, 2020, The 85th China International Pharmaceutical Equipment Exhibition (API China) and the 24th China International (industry) exhibition & Technology Exchange Conference (China-Pharm) opened …
June 18-20, 2019, The 19th International Convention on Pharmaceutical Ingredients and Intermediates China opened in Shanghai. Many well-known pharmaceutical enterprises from all over the world …
Approval Date Drug Name Application Number Active Ingredient Submit Type Company Name 2022-10-3 ALVAIZ NDA 216774 ELTROMBOPAG CHOLINE New active ingredients TEVA PHARMS 2022-10-6 NOREPINEPHRINE …
Copyright © NANJING XINBELL PHARMACEUTICAL TECHNOLOGY CO., LTD.All Rights Reserved. - privacy policy